Key Stats for IBM Stock
- Current Price: $229.87
- Target Price (Mid): ~$316
- Street Target: ~$244
- Potential Total Return: ~38%
- Annualized IRR: ~8% / year
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free) >>>
What Happened?
International Business Machines Corporation (IBM) had the worst day of its 115-year life on July 14, 2026. Shares fell 25.21% to close at $217.07, a steeper single-session drop than Black Monday in 1987, erasing roughly $67 billion in market value after the company pre-announced a weak second quarter. Six weeks later the stock has recovered to $229.87, but it still sits about 30% below the $332.46 high it set on June 2.
Was the crash a repricing of a broken business, or an overreaction to a timing problem? The answer hinges on something the market cannot yet confirm: whether the revenue that vanished in June was deferred or destroyed.
The Quarter Was a Timing Story, Not a Demand Story
Software growth of 5% badly missed the double-digit pace IBM had guided to, and management cut the full-year software range to 6% to 8% because of it. But the miss was concentrated, not broad. The recurring, AI-adjacent lines held up: Red Hat accelerated to 11%, and the Data segment grew 18%. What actually broke was the mainframe. Infrastructure fell 7%, IBM Z revenue dropped 42% against a brutal prior-year comparison, and Transaction Processing software, the high-margin stack that rides on the mainframe, declined 9%, dragging the blended software number down with it.
In the final weeks of June, large clients redirected capital toward servers, storage, and memory to lock in supply before expected price increases, pushing dozens of large mainframe deals past the quarter’s close. CFO Jim Kavanaugh explained why that hit software so hard: “with every dollar of hardware revenue we land, we get $3 plus of software with long-term commitments.”
Management said that within three weeks of quarter-end, about one-third of the slipped deals had already closed. CEO Arvind Krishna framed the normal pace this way: “we would expect maybe 2/3 to 3/4 of them to close over the next 6 months.” A third done in three weeks runs ahead of that. In his words, it is a good indication this was a deferral, though not yet full proof.
See historical and forward estimates for IBM stock (It’s free!) >>>
A Cash Engine That Runs While the Debate Plays Out
IBM generated $4.8 billion of free cash flow in the first half, flat year over year, and reaffirmed its target to grow full-year free cash flow by about $1 billion. Reaffirming that in the same quarter, a historic crash signals management sees the shortfall as recoverable. The recurring base backs the claim: roughly 80% of software revenue is now recurring, and annual recurring revenue reached $24.6 billion, up 8%.
IBM Z is still running near 130% of the prior z16 program, its strongest cycle on record, so installed-base demand looks intact. But Transaction Processing could stay soft into 2027, because clients can defer those upgrades on an operating-expense basis for years before the economics force their hand. That is the honest tension: demand appears deferred, and cash flow is holding, yet the exact timing of the recovery is genuinely hard to call.
Several securities law firms, including Bleichmar Fonti & Auld, have opened investigations into whether IBM misrepresented the pace of its deal pipeline and the strength of its IBM Z outlook before the crash. These are law-firm investigations soliciting shareholders, not a filed lawsuit or an SEC enforcement action, and the allegations are unproven. But they add a discount that a clean story would not carry.
See how IBM performs against its peers in TIKR (It’s free!) >>>
TIKR Advanced Model Analysis
- Current Price: $229.87
- Target Price (Mid): ~$316
- Potential Total Return: ~38%
- Annualized IRR: ~8% / year
See analysts’ growth forecasts and price targets for IBM stock (It’s free!) >>>
Two revenue drivers carry the mid-case. The first is the recurring software base, growing in the high single digits as Red Hat, HashiCorp, and Confluent scale on subscription and consumption models. The second is the mainframe recovery, as deferred Transaction Processing revenue converts on client upgrade cycles. The margin driver is IBM’s productivity program, which ran ahead of plan and now supports 100 basis points of operating pretax margin expansion this year despite the revenue shortfall. The primary risk is that the deferred demand proves partly destroyed, keeping the mainframe line and its software multiplier soft into 2027.
The upside case is that the slipped deals fully convert, the recurring base compounds toward double digits, and the multiple re-rates as the crash fades. The downside case is that the pipeline allegations gain substance or the mainframe recovery stalls, leaving IBM a low-growth business at a fair price rather than a cheap one.
The stock does screen cheaply on its own history. It trades near 13 times NTM EV/EBITDA and a NTM P/E near 18, both well below where IBM traded before the crash. For a business generating this much cash with a dividend yield near 2.9%, that discount looks more like fear than a permanent verdict, provided the deferred revenue shows up.
Conclusion
The next print, expected around October 21, is the next real test. Watch the mainframe first. If IBM Z holds near 130% program-to-program and management confirms the remaining slipped deals closed, the deferral thesis gains ground, and the discount should start to close. If Z slips further and Transaction Processing stays down in the high single digits, the fear that this was destruction gets harder to dismiss. The software recurring line approaching 10% growth is the confirmation signal; a stall there would be the break.
See what stocks billionaire investors are buying so you can follow the smart money with TIKR.
Should You Invest in IBM?
The only way to really know is to look at the numbers yourself. TIKR gives you free access to the same institutional-quality financial data that professional analysts use to answer exactly that question.
Pull up IBM, and you’ll see years of historical financials, what Wall Street analysts expect for revenue and earnings in the quarters ahead, how valuation multiples have moved over time, and whether price targets are trending up or down.
You can build a free watchlist to track IBM alongside every other stock on your radar. No credit card required. Just the data you need to decide for yourself.
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
